Literature DB >> 25410227

Pathology of human diabetic neuropathy.

R A Malik1.   

Abstract

Pathologic study of a disease provides insights into the precise mechanisms and targets of damage and may provide insights into new therapies. The main targets in diabetic neuropathy are myelinated and unmyelinated fibers as dysfunction and damage to them explains the symptoms of painful neuropathy and the major end points of foot ulceration and amputation as well as mortality. Demyelination and axonal degeneration are established hallmarks of the pathology of human diabetic neuropathy and were derived from pioneering light and electronmicroscopic studies of sural nerve biopsies in the late 1960s and early 1970s. Additional abnormalities, which are relevant to the pathogenesis of human diabetic neuropathy, include pathology of the microvessels and extracellular space. Intraepidermal and sudomotor nerve quantification in skin biopsies provides a minimally invasive means for the detection of early nerve damage. Studies of muscle biopsies are limited and show significant alterations in the expression of neurotrophins, but limited changes in muscle fiber size and capillary density.

Entities:  

Keywords:  Diabetic neuropathy; endoneurial capillaries; muscle biopsy; myelinated fibers; nerve biopsy; skin biopsy; unmyelinated fibers

Mesh:

Year:  2014        PMID: 25410227     DOI: 10.1016/B978-0-444-53480-4.00016-3

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  8 in total

1.  Topical Delivery of Muscarinic Receptor Antagonists Prevents and Reverses Peripheral Neuropathy in Female Diabetic Mice.

Authors:  Corinne G Jolivalt; Katie E Frizzi; May Madi Han; Andre J Mota; Lucie S Guernsey; Lakshmi P Kotra; Paul Fernyhough; Nigel A Calcutt
Journal:  J Pharmacol Exp Ther       Date:  2020-04-23       Impact factor: 4.030

2.  Blocking mitochondrial calcium release in Schwann cells prevents demyelinating neuropathies.

Authors:  Sergio Gonzalez; Jade Berthelot; Jennifer Jiner; Claire Perrin-Tricaud; Ruani Fernando; Roman Chrast; Guy Lenaers; Nicolas Tricaud
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

Review 3.  Aging, physical activity, and diabetic complications related to loss of muscle strength in patients with type 2 diabetes.

Authors:  Takuo Nomura; Toshihiro Kawae; Hiroaki Kataoka; Yukio Ikeda
Journal:  Phys Ther Res       Date:  2018-11-30

4.  Foretinib mitigates cutaneous nerve fiber loss in experimental diabetic neuropathy.

Authors:  Gregory H Borschel; Konstantin Feinberg; Simeon C Daeschler; Jennifer Zhang; Tessa Gordon
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

5.  Endoplasmic reticulum stress in the peripheral nervous system is a significant driver of neuropathic pain.

Authors:  Bora Inceoglu; Ahmed Bettaieb; Carlos A Trindade da Silva; Kin Sing Stephen Lee; Fawaz G Haj; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

6.  Relationship between peripheral neuropathy and cognitive performance in the elderly population.

Authors:  Yu-Jen Lin; Tung-Wei Kao; Wei-Liang Chen
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

Review 7.  Efficacy and Safety of the Injection of the Traditional Chinese Medicine Puerarin for the Treatment of Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis of 53 Randomized Controlled Trials.

Authors:  Baocheng Xie; Qinghui Wang; Chenhui Zhou; Jiahuan Wu; Daohua Xu
Journal:  Evid Based Complement Alternat Med       Date:  2018-01-24       Impact factor: 2.629

8.  Association of myelinated primary afferents impairment with mechanical allodynia in diabetic peripheral neuropathy: an experimental study in rats.

Authors:  Chenlong Liao; Min Yang; Wenxiang Zhong; Pengfei Liu; Wenchuan Zhang
Journal:  Oncotarget       Date:  2017-07-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.